Who can take PAXLOVID?
As much as we all wish
If you are at high risk for progression to severe
adults and children (12 years or older and 88 pounds [40 kg] or heavier), who
have had mild-to-moderate
have a high-risk factor for progression to severe
PAXLOVID is not approved to prevent COVID-19, treat severe or critical COVID-19, or to be used for more than 5 days. There are certain medications that should not be taken with PAXLOVID.
It’s estimated that more than half of American adults have at least one
risk factor for progression to severe COVID-19 . You could
be one of them.
Some of the most common risk factors for progression to severe
COVID-19 include:
- Age of 50+ years
-
Certain health conditions and diseases, such as heart disease and diabetes
- Being overweight or obese
- Mental health conditions
- Lifestyle factors, such as smoking
- Physical, mental, and developmental disabilities

Some of the most common risk factors for progression to severe
COVID-19 include:
- Age of 50+ years
-
Certain health conditions and diseases, such as heart disease and diabetes
- Being overweight or obese
- Mental health conditions
- Lifestyle factors, such as smoking
- Physical, mental, and developmental disabilities
A trial compared the risk of COVID-19–related hospitalization or death in people treated with PAXLOVID vs placebo.
It’s important to understand the risks and possible side effects of PAXLOVID before starting treatment.
Be prepared for
If you’re at high risk for progression to severe
Be prepared for
If you’re at high risk for progression to severe
How to verify your tablets are authentic
PAXLOVID must be prescribed by a licensed healthcare professional and supplied by a government-approved pharmacy or medical facility.
Authentic PAXLOVID, from Pfizer Inc., will include the Pfizer name on the label and will be packaged in 5 aluminum push-through blister cards. Individual doses are not for sale. PAXLOVID will be packaged in a rectangular carton. The carton has a colorless, glossy coating that contains a repeated pattern of the Pfizer name and logo all over, and these repeating features are seen in a contrasting matte finish.
PAXLOVID consists of tablets for a 5-day oral treatment regimen, with morning and evening doses.
NOTE: If you are a patient with moderate kidney disease, you may receive a carton with daily blister cards that have been modified to ensure you receive the correct dose.
To help determine whether the tablets are authentic, look for specific text on each side of the tablets
Tablet | Embossed Text |
---|---|
nirmatrelvir | Front: 3CL | Back: PFE |
ritonavir, manufactured by AbbVie | Front: ![]() |
ritonavir, manufactured by Hetero | Front: H | Back: R9 |
Pfizer is committed to patient safety and ensuring that people have accurate information about the investigational drug PAXLOVID, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate PAXLOVID to protect patients from products that might be dangerous and lead to serious and life-threatening harm.
If you suspect the product you have received may be counterfeit, contact us at
For more information
Contact one of the following groups:
For medical information visit www.pfizermedicalinformation.com or
For general product inquiries